review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0378-3782(98)00045-0 |
P698 | PubMed publication ID | 10193929 |
P2093 | author name string | Ikegami M | |
Jobe AH | |||
P2860 | cites work | Air opening pressure in fetal lungs | Q33472311 |
Static volume-pressure relations of excised lungs of infants with hyaline membrane disease, newborn and stillborn infants | Q34102758 | ||
Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia | Q34446393 | ||
Evaluation of criteria for chronic lung disease in surviving very low birth weight infants. Newborn Lung Project | Q34456968 | ||
Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model | Q37364413 | ||
Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth | Q37369026 | ||
Permissive hypercapnic ventilation | Q40704038 | ||
Formation of pulmonary alveoli and gas-exchange surface area: quantitation and regulation | Q41117812 | ||
Rate of bronchopulmonary dysplasia as a function of neonatal intensive care practices | Q41121651 | ||
Ventilator-induced lung injury: lessons from experimental studies | Q41691457 | ||
Inflammatory mediators and bronchopulmonary dysplasia | Q42117443 | ||
The critical concentration of surfactant in fetal lung liquid at birth | Q43597154 | ||
The Association of Occult Amniotic Fluid Infection With Gestational Age and Neonatal Outcome Among Women in Preterm Labor | Q43733978 | ||
Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. | Q46011333 | ||
High lung inflation increases mRNA levels of ECM components and growth factors in lung parenchyma | Q46475729 | ||
Tidal volume effects on surfactant treatment responses with the initiation of ventilation in preterm lambs | Q46569051 | ||
Very-low-birth-weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, May 1991 through December 1992. | Q47345073 | ||
Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. | Q50113611 | ||
Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf. | Q50949616 | ||
Lung volumes and pressure-volume relations of the respiratory system in small ventilated neonates with severe respiratory distress syndrome. | Q51582392 | ||
Optimizing alveolar expansion prolongs the effectiveness of exogenous surfactant therapy in the adult rabbit. | Q51656273 | ||
Lung volume maintenance prevents lung injury during high frequency oscillatory ventilation in surfactant-deficient rabbits. | Q51772753 | ||
Elevated laminin concentrations in lung secretions of preterm infants supported by mechanical ventilation are correlated with radiographic abnormalities. | Q52528206 | ||
Tidal ventilation at low airway pressures can augment lung injury. | Q55065976 | ||
Amniotic fluid tumor necrosis factor-α and the risk of respiratory distress syndrome among preterm infants | Q57282345 | ||
Corticosteroid and thyrotropin-releasing hormone effects on preterm sheep lung function | Q67994381 | ||
Elevation of fibronectin levels in lung secretions of infants with respiratory distress syndrome and development of bronchopulmonary dysplasia | Q68080345 | ||
Pathophysiologic, morphometric, and biochemical studies of the premature baboon with bronchopulmonary dysplasia | Q68083062 | ||
The effects of preterm delivery and mechanical ventilation on human lung growth | Q69127433 | ||
Risk factors for chronic lung disease in infants with birth weights of 751 to 1000 grams | Q69209123 | ||
Ventilator-related pathology in the extremely immature lung | Q69551922 | ||
Determinants of the first inspiratory volume and functional residual capacity at birth | Q69626818 | ||
Chest wall restriction limits high airway pressure-induced lung injury in young rabbits | Q69652130 | ||
Changes in lung volume and deflation stability in hyaline membrane disease | Q69827754 | ||
Alveolar development in the human fetus and infant | Q70028851 | ||
Physiologic responses to prolonged and slow-rise inflation in the resuscitation of the asphyxiated newborn infant | Q70914212 | ||
Changes in lung volume and static expiratory pressure-volume diagram after surfactant rescue treatment of neonates with established respiratory distress syndrome | Q71718423 | ||
Postnatal lung function in lambs after fetal hormone treatment. Effects of gestational age | Q71723687 | ||
Association of Ureaplasma urealyticum colonization with chronic lung disease of prematurity: results of a metaanalysis | Q71749771 | ||
Antenatal corticosteroid therapy: A meta-analysis of the randomized trials, 1972 to 1994 | Q71949152 | ||
Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia | Q71954076 | ||
Reduction in lung injury after combined surfactant and high-frequency ventilation | Q72105424 | ||
Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome | Q72279546 | ||
Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs | Q73667272 | ||
Role of neutrophils in lung vascular injury and edema after premature birth in lambs | Q73807110 | ||
Necrotizing funisitis: clinical significance and association with chronic lung disease in premature infants | Q74019207 | ||
Intra-amniotic interleukin-1 alpha treatment alters postnatal adaptation in premature lambs | Q74039638 | ||
P433 | issue | 1 | |
P921 | main subject | pulmonary injury | Q7259546 |
P304 | page(s) | 81-94 | |
P577 | publication date | 1998-11-01 | |
P1433 | published in | Early Human Development | Q5326666 |
P1476 | title | Mechanisms initiating lung injury in the preterm | |
P478 | volume | 53 |
Q41139957 | A comparison of high-frequency jet ventilation and synchronised intermittent mandatory ventilation in preterm lambs |
Q51660202 | A lung recruitment maneuver immediately before rescue surfactant therapy does not affect the lung mechanical response in immature lambs with respiratory distress syndrome. |
Q37144340 | Accelerated thymic maturation and autoreactive T cells in bronchopulmonary dysplasia |
Q38101107 | Acute lung injury in preterm fetuses and neonates: mechanisms and molecular pathways. |
Q37138909 | Airway inflammatory cell responses to intra-amniotic lipopolysaccharide in a sheep model of chorioamnionitis |
Q44647116 | Angiotensin II Receptor Blockade Inhibits Pneumocyte Apoptosis in Experimental Meconium Aspiration |
Q26798069 | Animal Models, Learning Lessons to Prevent and Treat Neonatal Chronic Lung Disease |
Q36530748 | Antecedents of chronic lung disease following three patterns of early respiratory disease in preterm infants |
Q35095591 | Antenatal factors and the development of bronchopulmonary dysplasia |
Q24791731 | Antenatal infection/inflammation and postnatal lung maturation and injury |
Q43660336 | Anti-neutrophil chemokine preserves alveolar development in hyperoxia-exposed newborn rats |
Q35590178 | Apoptosis in lung development and neonatal lung injury |
Q37174565 | Association of interferon gamma T+874A and interleukin 12 p40 promoter CTCTAA/GC polymorphism with the need for respiratory support and perinatal complications in low birthweight neonates |
Q47993305 | Atypical chronic lung disease in preterm infants |
Q24811959 | Bench-to-bedside review: Ventilator strategies to reduce lung injury -- lessons from pediatric and neonatal intensive care |
Q26750310 | Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant |
Q43936962 | Blocking neutrophil influx reduces DNA damage in hyperoxia-exposed newborn rat lung |
Q33857159 | Body temperature effects on lung injury in ventilated preterm lambs |
Q36102816 | Bombesin-like peptides modulate alveolarization and angiogenesis in bronchopulmonary dysplasia. |
Q30480109 | Brief, large tidal volume ventilation initiates lung injury and a systemic response in fetal sheep. |
Q35077309 | Bronchopulmonary dysplasia early changes leading to long-term consequences |
Q40479808 | Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies. |
Q95798019 | Case 4: assessment. Early chronic lung disease |
Q34778289 | Cellular biomechanics in the lung |
Q33840516 | Chorioamnionitis stimulates angiogenesis in saccular stage fetal lungs via CC chemokines |
Q39005196 | Citation context and impact of 'sleeping beauties' in paediatric research |
Q36403068 | Contribution of inflammation to lung injury and development |
Q35167355 | Current perspectives on the prevention and management of chronic lung disease in preterm infants |
Q40684981 | Current surfactant use in premature infants |
Q46500917 | Cytidine 5'-diphosphocholine ameliorates hyperoxic lung injury in a neonatal rat model. |
Q44887751 | Cytokines and oxygen radicals after hyperoxia in preterm and term alveolar macrophages |
Q28579300 | Developmental expression of the receptor for advanced glycation end-products (RAGE) and its response to hyperoxia in the neonatal rat lung |
Q51457987 | Doxapram Dosing for Apnea of Prematurity Based on Postmenstrual Age and Gender: A Randomized Controlled Trial. |
Q51681471 | Early use of high frequency ventilation in the premature neonate. |
Q35044459 | Effect of recombinant IL-10 on cultured fetal rat alveolar type II cells exposed to 65%-hyperoxia |
Q54542170 | Effects of intra-amniotic endotoxin on lung structure and function two months after term birth in sheep. |
Q44475527 | Effects of the plasticiser DEHP on lung of newborn rats: catalase immunocytochemistry and morphometric analysis. |
Q36756322 | Endoglin (CD105) up-regulation in pulmonary microvasculature of ventilated preterm infants |
Q37223145 | Erythropoietin attenuates hyperoxia-induced lung injury by down-modulating inflammation in neonatal rats |
Q93030614 | European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update |
Q36811513 | European consensus guidelines on the management of neonatal respiratory distress syndrome |
Q61805599 | Experimental Evaluation of Perfluorocarbon Aerosol Generation with Two Novel Nebulizer Prototypes |
Q52679011 | Experimental and Numerical Modeling of Aerosol Delivery for Preterm Infants. |
Q44198485 | Extracellular superoxide dismutase protects lung development in hyperoxia-exposed newborn mice |
Q37180285 | Fate and effects of adult bone marrow cells in lungs of normoxic and hyperoxic newborn mice |
Q35816454 | Foxm1 regulates resolution of hyperoxic lung injury in newborns |
Q38110743 | Gas exchange in the respiratory distress syndromes |
Q36238254 | Genome-wide transcriptional profiling reveals connective tissue mast cell accumulation in bronchopulmonary dysplasia |
Q37144572 | Growth of pulmonary microvasculature in ventilated preterm infants |
Q47847437 | HFOV in premature neonates: effects on pulmonary mechanics and epithelial lining fluid cytokines. A randomized controlled trial |
Q28285733 | High flow nasal cannula versus nasal CPAP for neonatal respiratory disease: a retrospective study |
Q51557012 | High flow nasal heliox improves work of breathing and attenuates lung injury in a newborn porcine lung injury model. |
Q47278599 | High tidal volume ventilation causes different inflammatory responses in newborn versus adult lung |
Q41817932 | Highlight Commentary on "Influence of lung oxidant and antioxidant status on alveolarization: Role of light-exposed total parenteral nutrition". |
Q42567604 | Hyperoxia exposure alters hepatic eicosanoid metabolism in newborn mice. |
Q40664954 | IL8 gene as modifier of cystic fibrosis: unraveling the factors which influence clinical variability |
Q37142998 | In utero ethanol exposure impairs defenses against experimental group B streptococcus in the term Guinea pig lung |
Q48001366 | Incomplete protection by prophylactic surfactant against the adverse effects of large lung inflations at birth in immature lambs |
Q57671312 | Increased Postnatal Inflammation in Mechanically Ventilated Preterm Infants Born to Mothers with Early-Onset Preeclampsia |
Q35556545 | Infection with Ureaplasma urealyticum: is there a specific clinical and radiological course in the preterm infant? |
Q35095600 | Inflammation and bronchopulmonary dysplasia |
Q37148925 | Inflammation induced by lipopolysaccharide does not prevent the vitamin A and retinoic acid-induced increase in retinyl ester formation in neonatal rat lungs |
Q37106309 | Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia. |
Q48630568 | Influence of preterm onset of inspiration on tidal breathing parameters in infants with and without CLD |
Q59317173 | Inhaled nitric oxide attenuates pulmonary inflammation and fibrin deposition and prolongs survival in neonatal hyperoxic lung injury |
Q53721382 | Interleukin-10 protects cultured fetal rat type II epithelial cells from injury induced by mechanical stretch. |
Q43406278 | Intra and interobserver reliability of the interpretation of high-resolution computed tomography on the lungs of premature infants |
Q37040828 | Intratracheal administration of endotoxin attenuates hyperoxia-induced lung injury in neonatal rats |
Q51727024 | Intratracheal endotoxin causes systemic inflammation in ventilated preterm lambs. |
Q43141834 | Intrauterine neutrophil activation is associated with pulmonary haemorrhage in preterm infants |
Q92441159 | Length at birth z-score is inversely associated with an increased risk of bronchopulmonary dysplasia or death in preterm infants born before 32 gestational weeks: A nationwide cohort study |
Q39029148 | Looking ahead: where to next for animal models of bronchopulmonary dysplasia? |
Q43690556 | Loop diuretics and in vitro relaxation of human fetal and newborn mouse airways |
Q51689812 | Lung epithelial cells undergo apoptosis in neonatal respiratory distress syndrome. |
Q47408329 | Lung mechanics and high-resolution computed tomography of the chest in very low birth weight premature infants |
Q74566080 | Lung recruitment at birth does not improve lung function in immature lambs receiving surfactant |
Q51369587 | Lung volume recruitment in lambs during high-frequency oscillatory ventilation using respiratory inductive plethysmography. |
Q37893906 | Lung-protective ventilation in neonatology |
Q54414256 | Maternal deprivation decelerates postnatal morphological lung development of F344 rats. |
Q34493101 | Maternal docosahexaenoic acid supplementation decreases lung inflammation in hyperoxia-exposed newborn mice. |
Q47985024 | Mechanical ventilation effect on surfactant content, function, and lung compliance in the newborn rat. |
Q36504534 | Mechanisms to explain surfactant responses |
Q35658721 | Mechanotransduction via TRPV4 regulates inflammation and differentiation in fetal mouse distal lung epithelial cells |
Q35674277 | Minimising the use of assisted ventilation to reduce the risk of chronic lung disease: a tried and tested management |
Q46628246 | Modulation of IGF-binding protein-2 and -3 in hyperoxic injury in developing rat lung |
Q43738953 | Morbidity and mortality patterns in small-for-gestational age infants born preterm |
Q44904443 | Na-K-2Cl cotransporter inhibition impairs human lung cellular proliferation |
Q52873803 | Nasal high-frequency oscillation ventilation in neonates: a survey in five European countries. |
Q35219845 | Neonatal hyperoxia contributes additively to cigarette smoke-induced chronic obstructive pulmonary disease changes in adult mice |
Q45213492 | Neonatal neutrophils with prolonged survival exhibit enhanced inflammatory and cytotoxic responsiveness |
Q38988590 | Neurally adjusted ventilator assist in very low birth weight infants: Current status |
Q37162755 | Nrf2 increases survival and attenuates alveolar growth inhibition in neonatal mice exposed to hyperoxia |
Q44945408 | Pentoxifylline reduces fibrin deposition and prolongs survival in neonatal hyperoxic lung injury |
Q51987547 | Perinatal increases in TGF-{alpha} disrupt the saccular phase of lung morphogenesis and cause remodeling: microarray analysis. |
Q36923696 | Permissive hypercapnia and risk for brain injury and developmental impairment |
Q34465163 | Permissive hypercapnia in neonates: the case of the good, the bad, and the ugly |
Q47448101 | Physiological and anatomical dead space in mechanically ventilated newborn infants |
Q44200361 | Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants |
Q51689818 | Positive pressure ventilation with the open lung concept optimizes gas exchange and reduces ventilator-induced lung injury in newborn piglets. |
Q34502529 | Postnatal Infections and Immunology Affecting Chronic Lung Disease of Prematurity |
Q30907696 | Postnatal steroid treatment and brain development |
Q46765903 | Pre-term pre-labour rupture of membranes: effect of chorioamnionitis on overall neonatal outcome |
Q35094703 | Pressure- versus volume-limited sustained inflations at resuscitation of premature newborn lambs. |
Q84525024 | Prevention of bronchopulmonary dysplasia |
Q24201075 | Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants |
Q36200439 | Protective lung strategies during artificial ventilation in children |
Q37183717 | Pulmonary Biomarkers of Bronchopulmonary Dysplasia |
Q52597843 | Pulmonary dendritic cells in lungs of preterm infants: neglected participants in bronchopulmonary dysplasia? |
Q37778598 | Pulmonary hypertension in chronic neonatal lung disease |
Q36453829 | Pulmonary inflammation and bronchopulmonary dysplasia |
Q47342990 | Pulse oximetry in very low birth weight infants: can oxygen saturation be maintained in the desired range? |
Q99404775 | Respiratory Support of the Preterm Neonate: Lessons About Ventilation-Induced Brain Injury From Large Animal Models |
Q24235327 | Respiratory function monitoring to reduce mortality and morbidity in newborn infants receiving resuscitation |
Q24239946 | Respiratory function monitoring to reduce mortality and morbidity in newborn infants receiving resuscitation |
Q35979931 | Respiratory management of the premature infant in the delivery room |
Q46738580 | Retinol-binding protein, transthyretin, and C-reactive protein in extremely low birth weight (ELBW) infants |
Q47694239 | Review shows that using surfactant a number of times or as a vehicle for budesonide may reduce the risk of bronchopulmonary dysplasia |
Q61803570 | Role of Nrf2 and Its Activators in Respiratory Diseases |
Q51266418 | Selective surfactant prophylaxis in preterm infants born at < or =31 weeks' gestation using the stable microbubble test in gastric aspirates. |
Q39787545 | Short-term outcomes of infants of substance-using mothers admitted to neonatal intensive care units in New South Wales and the Australian Capital Territory |
Q37190561 | Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury. |
Q93197602 | Small Molecule Inhibitor Adjuvant Surfactant Therapy Attenuates Ventilator- and Hyperoxia-Induced Lung Injury in Preterm Rabbits |
Q73728754 | Statement on the care of the child with chronic lung disease of infancy and childhood |
Q47824030 | Stereological monitoring of mouse lung alveolarization from the early postnatal period to adulthood. |
Q33868606 | Surfactant protein-d inhibits lung inflammation caused by ventilation in premature newborn lambs |
Q37168232 | Sustainable use of continuous positive airway pressure in extremely preterm infants during the first week after delivery |
Q96294063 | T-piece resuscitator or self-inflating bag during neonatal resuscitation: a scoping review |
Q38268677 | The Efficacy of Surfactant Replacement Therapy in the Growth-Restricted Preterm Infant: What is the Evidence? |
Q26771338 | The Extracellular Matrix in Bronchopulmonary Dysplasia: Target and Source |
Q36980502 | The Fas system confers protection against alveolar disruption in hyperoxia-exposed newborn mice |
Q36536002 | The pharmacokinetics and effects of a long-acting preparation of superoxide dismutase (PC-SOD) in man |
Q44556351 | The relationship between placental and other perinatal risk factors for neurologic impairment in very low birth weight children |
Q35040293 | Therapies administered to mothers at risk for preterm birth and neurodevelopmental outcome in their infants |
Q39263181 | Towards evidence-based resuscitation of the newborn infant |
Q35754860 | Transfer of the active form of transforming growth factor-beta 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia |
Q34545055 | Understanding the mechanisms of infant respiratory distress and chronic lung disease |
Q39520741 | Ureaplasma urealyticum modulates endotoxin-induced cytokine release by human monocytes derived from preterm and term newborns and adults |
Q43558050 | Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia |
Q84581982 | Variable ventilation enhances ventilation without exacerbating injury in preterm lambs with respiratory distress syndrome |
Q84089787 | Variable ventilation improves ventilation and lung compliance in preterm lambs |
Q54501115 | Vascular changes after intra-amniotic endotoxin in preterm lamb lungs. |
Q50609018 | Volume guarantee pressure support ventilation in extremely preterm infants and neurodevelopmental outcome at 18 months. |
Q34379827 | Volutrauma. What is it, and how do we avoid it? |
Q81522942 | [Postnatal steroid treatment in preterm infants: risk/benefit ratio] |
Q35879501 | rIL-10 enhances IL-10 signalling proteins in foetal alveolar type II cells exposed to hyperoxia |
Search more.